# OrthoPediatrics Corp. (KIDS) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Technology. Price $22.41, market value $585 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). OrthoPediatrics Corp. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.3×**. Each dollar of revenue is priced at 2.3×.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -0.3%** (5-yr avg -4.6%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 73.7%**. OrthoPediatrics Corp. keeps 73.7% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -11.9%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -16.8%**. The company reported a net loss over the last twelve months.
- **Return on equity: -11.4%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -5.5%**. Return on all capital, debt included, is -5.5%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -7.8%**. Each dollar of assets produces -7.8% of profit.

## Growth
- **Revenue growth (1 yr): 15.4%** (3-yr 24.6%/yr, 5-yr 27.2%/yr). Revenue grew 15.4% over the last year, against 27.2% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -3.0%**. Earnings per share fell 3.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.29**. Debt is 0.29 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. OrthoPediatrics Corp. holds more cash than debt.
- **Altman Z-score: 3.33**. A Z-score of 3.33 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. OrthoPediatrics Corp. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 8.2%** (YTD 26.2%, 3-mo 22.3%). The shares are up 8.2% over twelve months including dividends.
- **From 52-week high: -16.2%** (55.4% above the low). Trading 16% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 44**. An RSI of 44 is neutral.
- **Beta (1 yr): 0.91** (volatility 44%). Beta of 0.91 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=KIDS · Page: https://foliofundamentals.com/stocks/kids

Not investment advice.